A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This study uses a single arm, multi-center, open-label trial design. The study will assess
the efficacy and safety of 52 weeks of treatment with deferasirox (ICL670) in patients with
evidence of transfusion induced iron overload.